2m 2m 2m 2m 2m 2m 2m
NURIX THERAPEUTC-RG (NRIX)
NASDAQ
$26.72$0.00 (0.00%)
Price as of Aug 21, 2026 7:30 PM EDT- $2.8BMarket Cap
- 163.51%1-Year Change
- BiotechnologyIndustry
NURIX THERAPEUTC-RG (NRIX)
$26.72$0.00 (0.00%)
NRIX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $26.72 | ||
Change | -$0.33 (-1.22%) | ||
Open | $27.41 | ||
High | $27.50 | ||
Low | $26.70 | ||
Previous Close | $27.05 | ||
Volume | 1,485,867 | ||
30-Day Average Volume | 1,100,400 | ||
1-Week Change | -1.22% | ||
1-Month Change | 13.80% | ||
1-Year Change | 163.51% | ||
3-Year Change | 211.42% | ||
5-Year Change | -15.23% | ||
Fundamentals | |||
Shares Outstanding | 103.8M | ||
Total Assets | $535.5M | ||
Market Cap | $2.8B | ||
Enterprise Value | $2.7B | ||
Period: QTR TTM FY | |||
Revenue | $9.0M | ||
Net Income | -$89.5M | ||
Free Cash Flow | -$98.5M | ||
EBIT | -$89.8M | ||
EBITDA | -$87.6M | ||
Net Working Capital | $384.5M | ||
EPS | -$0.81 | ||
Enterprise Value/EBITDA | -31 | ||
Enterprise Value/Revenue | 299 | ||
P/B | 7 | ||
P/E | -33 | ||
PEG | 13 | ||
Price/Free Cash Flow | -28 | ||
Price/Operating Cash Flow | -29 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue